Patents Assigned to Board of Regents of the University of Washington
  • Patent number: 7842478
    Abstract: The present invention relates to novel purified and isolated nucleotide sequences encoding mammalian Ca2+/calmodulin stimulated phosphodiesterases (CaM-PDEs) and cyclic-GMP-stimulated phosphodiesterases (cGS-PDEs). Also provided are the corresponding recombinant expression products of said nucleotide sequences, immunological reagents specifically reactive therewith, and procedures for identifying compounds which modulate the enzymatic activity of such expression products.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: November 30, 2010
    Assignee: The Board of Regents of the University of Washington
    Inventors: Joseph A. Beavo, J. Kelley Bentley, Harry Charbonneau, William K. Sonnenburg
  • Patent number: 7122363
    Abstract: The present invention relates to novel purified and isolated nucleotide sequences encoding mammalian Ca2+/calmodulin stimulated phosphodiesterases (CaM-PDEs) and cyclic-GMP-stimulated phosphodiesterases (cGS-PDEs). Also provided are the corresponding recombinant expression products of said nucleotide sequences, immunological reagents specifically reactive therewith, and procedures for identifying compounds which modulate the enzymatic activity of such expression products.
    Type: Grant
    Filed: October 30, 2003
    Date of Patent: October 17, 2006
    Assignee: The Board of Regents of the University of Washington
    Inventors: Joseph A. Beavo, Kelley J. Bentley, Harry Charbonneau, William K. Sonnenburg
  • Patent number: 6867020
    Abstract: The Apa I restriction fragment of the human erythropoietin gene, for producing high titers of biologically active hormone from stably transfected cell lines.
    Type: Grant
    Filed: October 10, 2001
    Date of Patent: March 15, 2005
    Assignee: The Board of Regents of the University of Washington
    Inventor: Jerry S. Powell
  • Patent number: 6642040
    Abstract: The present invention relates to novel purified and isolated nucleotide sequences encoding mammalian Ca2+/calmodulin stimulated phosphodiesterases (CaM-PDEs) and cyclic-GMP-stimulated phosphodiesterases (cGS-PDEs). Also provided are the corresponding recombinant expression products of said nucleotide sequences, immunological reagents specifically reactive therewith, and procedures for identifying compounds which modulate the enzymatic activity of such expression products.
    Type: Grant
    Filed: June 18, 2001
    Date of Patent: November 4, 2003
    Assignee: The Board of Regents of the University of Washington
    Inventors: Joseph A. Beavo, Kelley J. Bentley, Harry Charbonneau, William K. Sonnenburg
  • Publication number: 20030006770
    Abstract: An MRI apparatus and method useful for both industrial applications and medical applications is provided. The apparatus and procedures are capable of estimating the value of a continuous property, such as concentration, viscosity or the like by interpolating or extrapolating from a model derived from training sets of data representing measurements of samples with known properties. A number of techniques are provided for objectifying the analysis. Cluster analysis techniques can be used to supplement, assist or replace subjective judgments by trained operators. Calculations or judgments regarding similarity can be made with respect to stored libraries of signatures, particularly where the library of stored signatures is obtained objectively, e.g., using cluster analysis, standardization and calibration. The signatures can be expanded signatures which include non-MR as well as MR data.
    Type: Application
    Filed: March 19, 2002
    Publication date: January 9, 2003
    Applicant: Board of Regents of the University of Washington
    Inventor: Justin P. Smith
  • Publication number: 20020151024
    Abstract: The present invention relates to novel purified and isolated nucleotide sequences encoding mammalian Ca2+/calmodulin stimulated phosphodiesterases (CaM-PDEs) and cyclic-GMP-stimulated phosphodiesterases (cGS-PDEs). Also provided are the corresponding recombinant expression products of said nucleotide sequences, immunological reagents specifically reactive therewith, and procedures for identifying compounds which modulate the enzymatic activity of such expression products.
    Type: Application
    Filed: June 18, 2001
    Publication date: October 17, 2002
    Applicant: The Board of Regents of the University of Washington
    Inventors: Joseph A. Beavo, J. Kelley Bentley, Harry Charbonneau, William K. Sonnenburg
  • Patent number: 6304870
    Abstract: A procedure is disclosed for automatically constructing wrappers for performing information-extraction from sites such as Internet resources that display relevant information, interspersed with extraneous text fragments, such as HTML formatting commands or advertisements. The procedure has three basic steps. First, a set of example pages are collected with a subroutine named GatherExamples. Gather Examples is provided with information describing how to pose example queries to the site whose wrapper is to be learned. Second, these example pages are labeled by a subroutine named LabelExamples—i.e., the information to be extracted from each example is identified for use in the third step. The LabelExamples subroutine uses a general framework for labeling pages using site-specific heuristics called recognizers, as well as allowing users to correct and modify the recognized instances. Finally, the labeled example pages are passed to a BuildWrapper subroutine, which constructs a wrapper.
    Type: Grant
    Filed: December 2, 1997
    Date of Patent: October 16, 2001
    Assignee: The Board of Regents of the University of Washington, Office of Technology Transfer
    Inventors: Nicholas Kushmerick, Daniel S. Weld, Robert B. Doorenbos
  • Patent number: 6161031
    Abstract: There is disclosed an apparatus for real-time imaging of cortical intrinsic signals or imaging tumor tissue or the margins, dimensions and grade of tumor tissue, comprising, a means for obtaining analog video images and a means for processing the analog video signals into either an averaged control frame or a subsequent frame, a means for acquiring and analyzing a plurality of subsequent frames and averaged control frame to provide a difference image, wherein the difference image is processed to account for movement and noise and amplify the changes across a dynamic range of the apparatus, and a means for displaying the difference image alone or superimposed over an analog video image.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: December 12, 2000
    Assignee: Board of Regents of the University of Washington
    Inventors: Daryl Hochman, Michael M. Haglund
  • Patent number: 6043225
    Abstract: Method of diagnosing arterial chlamydial granuloma by detecting in a biological sample both a first marker associated with Chlamydia pneumoniae and a second marker associated with arterial granuloma. Therapeutic composition for treating arterial chlamydial granulomatous disease, including an anti-Chlamydia pneumoniae agent and a granuloma inhibitor.
    Type: Grant
    Filed: January 13, 1998
    Date of Patent: March 28, 2000
    Assignees: Board of Regents of the University of Washington, Allan Shor
    Inventors: Allan Shor, Cho-chou Kuo
  • Patent number: 6037119
    Abstract: The present invention provides novel purified and isolated nucleotide sequences encoding the cGMP-binding, cGMP-specific phosphodiesterase designated cGB-PDE. Also provided by the invention are methods and materials for the recombinant production of cGB-PDE polypeptide products and methods for identifying compounds which modulate the enzymatic activity of cGB-PDE polypeptides.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: March 14, 2000
    Assignee: Board of Regents of the University of Washington
    Inventors: Joseph A. Beavo, Jackie D. Corbin, Kenneth M. Ferguson, Sharron H. Francis, Ann Kadlecek, Kate Loughney, Linda M. McAllister-Lucas, William K. Sonnenburg, Melissa K. Thomas
  • Patent number: 6025176
    Abstract: Human pancreatic islet cell glutamic acid decarboxylase (GAD), an autoantigen involved in the development of insulin-dependent diabetes mellitus (IDDM), has been cloned, sequenced and expressed by recombinant means. Recombinant human islet cell GAD polypeptides and antibodies specific to the GAD polypeptides can be used in methods of diagnosis and treatment, including use in immunoadsorptive therapy and the induction of immune tolerance.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: February 15, 2000
    Assignee: The Board of Regents of the University of Washington and ZymoGenetics, Inc.
    Inventors: Ake Lernmark, Allan E. Karlsen, Catherine E. Grubin, William Hagopian, Patrick J. O'Hara, Donald C. Foster
  • Patent number: 6022736
    Abstract: The present invention provides novel recombinant nucleic acid vectors which may be used to produce .alpha.-globin as well as other proteins of interest in quantity in the red blood cells of transgenic animals or cell cultures of erythroid lineage. The present invention also provides for the transgenic animals which contain these recombinant nucleic acid vectors. The vectors of the invention comprise at least one of the major DNase I hypersensitivity sites associated with the .beta.-globin locus together with a gene of interest. According to various embodiments of the invention, the vectors may be used to create transgenic animals or to transfect cells in culture. In a specific embodiment of the invention, a vector which comprises two DNase I hypersensitivity sites together with the human .alpha.-globin gene is used to create transgenic animals which produce human .alpha.-globin protein in erythroid tissues, including red blood cells.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: February 8, 2000
    Assignees: The UAB Research Foundation, The Trustees of the University of Pennsylvania, Board of Regents of the University of Washington
    Inventors: Tim M. Townes, Thomas M. Ryan, Richard D. Palmiter, Ralph L. Brinster, Richard R. Behringer
  • Patent number: 6015677
    Abstract: The present invention relates to novel purified and isolated nucleotide sequences encoding mammalian Ca.sup.2+ /calmodulin stimulated phosphodiesterases (CaM-PDEs) and cyclic-GMP-stimulated phosphodiesterases (cGS-PDEs). Also provided are the corresponding recombinant expression products of said nucleotide sequences, immunological reagents specifically reactive therewith, and procedures for identifying compounds which modulate the enzymatic activity of such expression products.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: January 18, 2000
    Assignee: The Board of Regents of the University of Washington
    Inventors: Joseph A. Beavo, Kelley J. Bentley, Harry Charbonneau, William K. Sonnenburg
  • Patent number: 6008781
    Abstract: A virtual retinal display utilizes photon generation and manipulation to create a panoramic, high resolution, color virtual image that is projected directly onto the retina of the eye without creating a real or an aerial image that is viewed via a mirror or optics. The virtual retinal display includes a source of photons, the photons being modulated with video information and scanned in a raster type of pattern directly onto the retina of the user's eye. The photon generator may utilize coherent or non-coherent light. Further, the photon generator may utilize color light generators so as to scan a colored virtual image directly onto the retina of the user's eye. The virtual retinal display may also include a depth accommodation cue to vary the focus of scanned photons rapidly so as to control the depth perceived by a user for each individual picture element of the virtual image.
    Type: Grant
    Filed: August 13, 1997
    Date of Patent: December 28, 1999
    Assignee: Board of Regents of the University of Washington
    Inventors: Thomas Adrian Furness, III, Joel S. Kollin
  • Patent number: 5995959
    Abstract: This invention provides methods to locate and plan the retrieval of data from networked information sources in response to a user query. The methods utilize descriptions of the information sources, the information domain of the sources, and of the query. The methods of this invention integrate both legacy systems and full relational databases with an efficient, domain-independent, query-planning algorithm, reason about the capabilities of different information sources, handle partial goal satisfaction i.e., gather as much data as possible when all that the user requested cannot be gathered, are both sound and complete, and are efficient.
    Type: Grant
    Filed: January 23, 1998
    Date of Patent: November 30, 1999
    Assignee: The Board of Regents of the University of Washington
    Inventors: Marc T. Friedman, Chung T. Kwok, Daniel S. Weld
  • Patent number: 5976466
    Abstract: There is disclosed a diagnostic sensor device comprising a plurality of sensor probes, a detection device, and a computer for analyzing the signals generated from each sensor probe by multivariate statistical analysis. The plurality of sensor probes comprise a substrate that allows transmission of a signal and a partially selective surface coating the substrate wherein the partially selective surface binds proteins from a biological fluid by multiple, noncovalent interactions, and with the proviso that the partially selective surfaces of each sensor probe in the diagnostic sensor device be different. The diagnostic sensor device can be used as a method for diagnosing disease states in humans and animals, wherein the disease states are characterized by altered protein character and behavior of a biological fluid.
    Type: Grant
    Filed: April 15, 1992
    Date of Patent: November 2, 1999
    Assignee: The Board of Regents of the University of Washington
    Inventors: Buddy D. Ratner, James E. Francese
  • Patent number: 5958883
    Abstract: In vivo assays for selecting candidate therapeutics for inhibiting amyloidoses, such as congophilic and fibrillar .beta./A4 amyloid deposition in brain. A candidate reagent is administered to a first rat in a first infusate comprising .beta./A4 peptide and perlecan by continuous infusion into the hippocampus for at least one week. The candidate reagent is selected as a candidate therapeutic for inhibiting congophilic and fibrillar .beta./A4 amyloid deposition in brain if the first infusate diminishes congo red and thioflavin S staining indicative of amyloid deposition adjacent to the infusion site, as compared with a second rat receiving a second infusate consisting essentially of .beta./A4 peptide and perlecan.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: September 28, 1999
    Assignee: Board of Regents of the University of Washington Office of Technology
    Inventor: Alan D. Snow
  • Patent number: RE38981
    Abstract: Genomic and cDNA sequences coding for a protein having substantially the same biological activity as human protein C are disclosed. Recombinant plasmids and bacteriophage transfer vectors incorporating these sequences are also disclosed.
    Type: Grant
    Filed: August 13, 2002
    Date of Patent: February 14, 2006
    Assignee: Board of Regents of the University of Washington
    Inventors: Donald C. Foster, Earl W. Davie
  • Patent number: RE37958
    Abstract: Genomic and cDNA sequences coding for a protein having substantially the same biological activity as human protein C are disclosed. Recombinant plasmids and bacteriophage transfer vectors incorporating these sequences are also disclosed.
    Type: Grant
    Filed: June 15, 2001
    Date of Patent: January 7, 2003
    Assignee: Board of Regents of the University of Washington
    Inventors: Donald C. Foster, Earl W. Davie
  • Patent number: RE40811
    Abstract: The invention relates to in vivo peripheralization of CD34+ cells by administering anti-VLA-4 antibodies or anti-VCAM-1 antibodies.
    Type: Grant
    Filed: November 15, 1993
    Date of Patent: June 30, 2009
    Assignee: Board of Regents of the University of Washington
    Inventor: Thalia Papayannopoulou